A team of high school journalists on what's working — and what isn't — with Oregon's new ban on cell phones in schools.

Caribou Biosciences, Inc. recently reported very exciting early data, with more in the allogeneic CAR T-cell pipeline. Read ...

BMY's growth-driving portfolio increased 17% year-over-year, prompting an upward revision in 2025 revenue guidance and ...

Data demonstrate efficacy and durability of vispa-cel, an allogeneic anti-CD19 CAR-T cell therapy, are on par with autologous CAR-T cell therapies in the confirmatory cohort (N=22) and with ...

Oral presentation of GLPG5101 data from the ATALANTA-1 study in patients with high-risk relapsed/refractory mantle cell lymphoma ...

CULLMAN, Ala. — Thousands of cellphone users across four Alabama counties lost service Monday after a fiber optic line was ...

Preliminary data recently shared for eti-cel (UCART20x22) show an 86% ORR and a 57% CR rate (n=7), underscoring its potential ...

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces clinical data for CT0596, an allogeneic BCMA-targeting CAR-T ...

Students in Wisconsin’s K-12 schools are no longer allowed to use their cellphones during class time under a bipartisan bill ...

Science still faces mysteries like dark matter, consciousness, and the origin of life—questions that challenge researchers and push the limits of understanding.

In 2023, the worldwide clean energy market was estimated to be about $0.7 trillion, according to a report from Allied Market ...

Roche said its Gazyva drug met the key goals in a late-stage trial, significantly reducing symptoms of systemic lupus erythematosus.